You must be signed in to view this page
Palbociclib: A New Option for Front-Line Treatment of Metastatic, Hormone Receptor–Positive, HER2-Negative Breast Cancer
Volume 6, Number 6 (Nov/Dec 2015)
doi: 10.6004/jadpro.6.6.6
